{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:12:51Z","timestamp":1791670371071,"version":"4.3.4"},"posted":{"date-parts":[[2024,11,1]]},"group-title":"In Review","reference-count":128,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,10,9]]},"abstract":"<title>Abstract<\/title>\n        <p>SMOC1 has emerged as one of the most significant and consistent new biomarkers of early Alzheimer\u2019s disease (AD). Recent studies show that SMOC1 is one of the earliest changing proteins in AD, with levels in the cerebrospinal fluid increasing many years before symptom onset. Despite this clear association with disease, little is known about the role of SMOC1 in AD or its function in the brain. Therefore, the aim of this study was to examine the distribution of SMOC1 in human AD brain tissue and to determine if SMOC1 influenced amyloid beta (A\u03b2) aggregation. The distribution of SMOC1 in human brain tissue was assessed in 3 brain regions (temporal cortex, hippocampus, frontal cortex) using immunohistochemistry in a cohort of 73 cases encompassing advanced AD, mild cognitive impairment (MCI), preclinical AD and cognitively normal controls. The A\u03b2- and phosphorylated tau-interaction with SMOC1 was assessed in control, MCI and advanced AD human brain tissue using co-immunoprecipitation, and the influence of SMOC1 on A\u03b2 aggregation kinetics was assessed using Thioflavin T assays and electron microscopy. SMOC1 strongly colocalized with a subpopulation of amyloid plaques in AD (43.8\u00b12.4%), MCI (32.8\u00b15.4%) and preclinical AD (28.3\u00b16.4%). SMOC1 levels in the brain strongly correlated with plaque load, irrespective of disease stage. SMOC1 also colocalized with a subpopulation of phosphorylated tau aggregates in AD (9.6\u00b12.6%). Co-immunoprecipitation studies showed that SMOC1 strongly interacted with A\u03b2 in human MCI and AD brain tissue and with phosphorylated tau in human AD brain tissue. Thioflavin T aggregation assays showed that SMOC1 significantly delayed A\u03b2 aggregation in a dose-dependent manner, and electron microscopy confirmed that the A\u03b2 fibrils generated in the presence of SMOC1 had an altered morphology. Overall, our results emphasize the importance of SMOC1 in the onset and progression of AD and suggest that SMOC1 may influence pathology development in AD.<\/p>","DOI":"10.21203\/rs.3.rs-5229472\/v1","type":"posted-content","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:05:54Z","timestamp":1730448354000},"source":"Crossref","is-referenced-by-count":2,"title":["SMOC1 colocalizes with Alzheimer\u2019s disease neuropathology and delays A\u03b2 aggregation"],"prefix":"10.21203","author":[{"given":"Kaleah","family":"Balcomb","sequence":"first","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Johnston","sequence":"additional","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Leitner","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schneider","sequence":"additional","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Halliday","sequence":"additional","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wisniewski","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Sunde","sequence":"additional","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Drummond","sequence":"additional","affiliation":[{"name":"University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. (2017) Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimers Dement 13: 178\u2013182.e117 Doi 10.1016\/j.jalz.2016.12.006","DOI":"10.1016\/j.jalz.2016.12.006"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Abouzeid H, Boisset G, Favez T, Youssef M, Marzouk I, Shakankiry N, Bayoumi N, Descombes P, Agosti C, Munier FLet al (2011) Mutations in the SPARC-Related Modular Calcium-Binding Protein 1 Gene, SMOC1, Cause Waardenburg Anophthalmia Syndrome. The American Journal of Human Genetics 88: 92\u201398 Doi https:\/\/doi.org\/10.1016\/j.ajhg.2010.12.002","DOI":"10.1016\/j.ajhg.2010.12.002"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Adams KL, Gallo V (2018) The diversity and disparity of the glial scar. Nature neuroscience 21: 9\u201315","DOI":"10.1038\/s41593-017-0033-9"},{"key":"ref4","unstructured":"4. Afroz KF, Levites Y, Ryu D, Ran Y, Gadhavi JD, Liu X, Seyfried N, Golde T (2024) SPARC-related modular calcium-binding proteins (SMOC1 and 2) as a modulator of amyloid pathology in Alzheimer\u2019s Disease. Alzheimer's Association International Conference, City"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Ao X, Jiang M, Zhou J, Liang H, Xia H, Chen G (2019) lincRNA\u2011p21 inhibits the progression of non\u2011small cell lung cancer via targeting miR\u201117\u20115p. Oncol Rep 41: 789\u2013800 Doi 10.3892\/or.2018.6900","DOI":"10.3892\/or.2018.6900"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Aoki H, Takasawa A, Yamamoto E, Niinuma T, Yamano H-o, Harada T, Kubo T, Yorozu A, Kitajima H, Ishiguro Ket al (2024) Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas. BMC Gastroenterology 24: 91 Doi 10.1186\/s12876-024-03175-1","DOI":"10.1186\/s12876-024-03175-1"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yamano H-O, Harada T, Matsushita H-O, Yoshikawa K, Takagi R, Harada Eet al (2017) Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer. Oncotarget 9:","DOI":"10.18632\/oncotarget.23523"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Arai H, Emson P, Mountjoy C, Carassco L, Heizmann C (1987) Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia. Brain research 418: 164\u2013169","DOI":"10.1016\/0006-8993(87)90974-7"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Askenazi M, Kavanagh T, Pires G, Ueberheide B, Wisniewski T, Drummond E (2023) Compilation of reported protein changes in the brain in Alzheimer's disease. Nature communications 14: 4466 Doi 10.1038\/s41467-023-40208-x","DOI":"10.1038\/s41467-023-40208-x"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Bai B, Wang X, Li Y, Chen PC, Yu K, Dey KK, Yarbro JM, Han X, Lutz BM, Rao Set al (2020) Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression. Neuron 105: 975\u2013991 e977 Doi 10.1016\/j.neuron.2019.12.015","DOI":"10.1016\/j.neuron.2019.12.015"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SAet al (2021) Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598: 111\u2013119 Doi 10.1038\/s41586-021-03465-8","DOI":"10.1038\/s41586-021-03465-8"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Baracaldo-Santamar\u00eda D, Avenda\u00f1o-Lopez SS, Ariza-Salamanca DF, Rodriguez-Giraldo M, Calderon-Ospina CA, Gonz\u00e1lez-Reyes RE, Nava-Mesa MO (2023) Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer\u2019s Disease. International Journal of Molecular Sciences 24: 9067","DOI":"10.3390\/ijms24109067"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA (2018) Religious orders study and rush memory and aging project. Journal of Alzheimer's disease 64: S161-S189","DOI":"10.3233\/JAD-179939"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends in Neurosciences 31: 454\u2013463 Doi https:\/\/doi.org\/10.1016\/j.tins.2008.06.005","DOI":"10.1016\/j.tins.2008.06.005"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Bezprozvanny IB (2010) Calcium signaling and neurodegeneration. Acta Naturae 2: 72\u201382","DOI":"10.32607\/20758251-2010-2-1-72-80"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85: 1930\u20131936","DOI":"10.1212\/WNL.0000000000002175"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Braak H, Braak E (1995) Staging of alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging 16: 271\u2013278 Doi https:\/\/doi.org\/10.1016\/0197-4580(95)00021-6","DOI":"10.1016\/0197-4580(95)00021-6"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Brady DR, Mufson EJ (1997) Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain. Neuroscience 80: 1113\u20131125 Doi https:\/\/doi.org\/10.1016\/S0306-4522(97)00068-7","DOI":"10.1016\/S0306-4522(97)00068-7"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Brellier F, Ruggiero S, Zwolanek D, Martina E, Hess D, Brown-Luedi M, Hartmann U, Koch M, Merlo A, Lino Met al (2011) SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors. Matrix Biol 30: 225\u2013233 Doi 10.1016\/j.matbio.2011.02.001","DOI":"10.1016\/j.matbio.2011.02.001"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Bryois J, Calini D, Macnair W, Foo L, Urich E, Ortmann W, Iglesias VA, Selvaraj S, Nutma E, Marzin Met al (2022) Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nature Neuroscience 25: 1104\u20131112 Doi 10.1038\/s41593-022-01128-z","DOI":"10.1038\/s41593-022-01128-z"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Bu J, Sathyendra V, Nagykery N, Geula C (2003) Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Experimental Neurology 182: 220\u2013231 Doi https:\/\/doi.org\/10.1016\/S0014-4886(03)00094-3","DOI":"10.1016\/S0014-4886(03)00094-3"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Carlyle BC, Kandigian SE, Kreuzer J, Das S, Trombetta BA, Kuo Y, Bennett DA, Schneider JA, Petyuk VA, Kitchen RRet al (2021) Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging 105: 99\u2013114 Doi 10.1016\/j.neurobiolaging.2021.04.012","DOI":"10.1016\/j.neurobiolaging.2021.04.012"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Chamling X, Kallman A, Fang W, Berlinicke CA, Mertz JL, Devkota P, Pantoja IEM, Smith MD, Ji Z, Chang Cet al (2021) Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells. Nature Communications 12: 652 Doi 10.1038\/s41467-021-20892-3","DOI":"10.1038\/s41467-021-20892-3"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Chandran R, Kumar M, Kesavan L, Jacob RS, Gunasekaran S, Lakshmi S, Sadasivan C, Omkumar RV (2019) Cellular calcium signaling in the aging brain. Journal of Chemical Neuroanatomy 95: 95\u2013114 Doi https:\/\/doi.org\/10.1016\/j.jchemneu.2017.11.008","DOI":"10.1016\/j.jchemneu.2017.11.008"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Choi Y-A, Lim J, Kim KM, Acharya B, Cho J-Y, Bae Y-C, Shin H-I, Kim S-Y, Park EK (2010) Secretome Analysis of Human BMSCs and Identification of SMOC1 as an Important ECM Protein in Osteoblast Differentiation. Journal of Proteome Research 9: 2946\u20132956 Doi 10.1021\/pr901110q","DOI":"10.1021\/pr901110q"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Cox D, Selig E, Griffin MD, Carver JA, Ecroyd H (2016) Small Heat-shock Proteins Prevent alpha-Synuclein Aggregation via Transient Interactions and Their Efficacy Is Affected by the Rate of Aggregation. J Biol Chem 291: 22618\u201322629 Doi 10.1074\/jbc.M116.739250","DOI":"10.1074\/jbc.M116.739250"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Crist\u00f3v\u00e3o JS, Morris VK, Cardoso I, Leal SS, Mart\u00ednez J, Botelho HM, G\u00f6bl C, David R, Kierdorf K, Alemi Met al (2018) The neuronal S100B protein is a calcium-tuned suppressor of amyloid-\u03b2 aggregation. Science Advances 4: eaaq1702 Doi doi:10.1126\/sciadv.aaq1702","DOI":"10.1126\/sciadv.aaq1702"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Cruchaga C, Ali M, Shen Y, Do A, Wang L, Western D, Liu M, Beric A, Budde J, Gentsch Jet al (2024) Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease. Res Sq: Doi 10.21203\/rs.3.rs-3631708\/v1","DOI":"10.21203\/rs.3.rs-3631708\/v1"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Dai J, Johnson ECB, Dammer EB, Duong DM, Gearing M, Lah JJ, Levey AI, Wingo TS, Seyfried NT (2018) Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease. Front Mol Neurosci 11: 454 Doi 10.3389\/fnmol.2018.00454","DOI":"10.3389\/fnmol.2018.00454"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, Levey AI, Johnson ECB (2022) Multi-Platform Proteomic Analysis of Alzheimer\u2019s Disease Cerebrospinal Fluid and Plasma Reveals Network Biomarkers Associated with Proteostasis and the Matrisome. bioRxiv: 2022.2006.2020.494087 Doi 10.1101\/2022.06.20.494087","DOI":"10.1101\/2022.06.20.494087"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Dayon L, Nunez Galindo A, Wojcik J, Cominetti O, Corthesy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin Iet al (2018) Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res Ther 10: 66 Doi 10.1186\/s13195-018-0397-4","DOI":"10.1186\/s13195-018-0397-4"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. de Geus MB, Leslie SN, Lam T, Wang W, Roux-Dalvai F, Droit A, Kivisakk P, Nairn AC, Arnold SE, Carlyle BC (2023) Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer\u2019s disease in a large clinical sample. Scientific Reports 13: 22406 Doi 10.1038\/s41598-023-49440-3","DOI":"10.1038\/s41598-023-49440-3"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Delgado Lagos F, Elgheznawy A, Kyselova A, Meyer Zu Heringdorf D, Ratiu C, Randriamboavonjy V, Mann AW, Fisslthaler B, Siragusa M, Fleming I (2021) Secreted modular calcium-binding protein 1 binds and activates thrombin to account for platelet hyperreactivity in diabetes. Blood 137: 1641\u20131651 Doi 10.1182\/blood.2020009405","DOI":"10.1182\/blood.2020009405"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers. Journal of Biological Chemistry 280: 17294\u201317300","DOI":"10.1074\/jbc.M500997200"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S, Faustin A, Berdah V, Ueberheide B, Wisniewski T (2022) The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome. Acta neuropathologica communications 10: 53 Doi 10.1186\/s40478-022-01356-1","DOI":"10.1186\/s40478-022-01356-1"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S, Faustin A, Berdah V, Ueberheide B, Wisniewski T (2022) The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome. Acta Neuropathologica Communications 10: 53 Doi 10.1186\/s40478-022-01356-1","DOI":"10.1186\/s40478-022-01356-1"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han Xet al (2017) Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease. Acta Neuropathol 133: 933\u2013954 Doi 10.1007\/s00401-017-1691-0","DOI":"10.1007\/s00401-017-1691-0"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Safar J, Ueberheide B, Wisniewski T (2020) Phosphorylated tau interactome in the human Alzheimer's disease brain. Brain 143: 2803\u20132817 Doi 10.1093\/brain\/awaa223","DOI":"10.1093\/brain\/awaa223"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Fairless R, Williams SK, Diem R (2019) Calcium-Binding Proteins as Determinants of Central Nervous System Neuronal Vulnerability to Disease. International Journal of Molecular Sciences 20: 2146","DOI":"10.3390\/ijms20092146"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Falc\u00e3o AM, van Bruggen D, Marques S, Meijer M, J\u00e4kel S, Agirre E, Samudyata, Floriddia EM, Vanichkina DP, ffrench-Constant Cet al (2018) Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nature Medicine 24: 1837\u20131844 Doi 10.1038\/s41591-018-0236-y","DOI":"10.1038\/s41591-018-0236-y"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Fang LP, Bai X (2023) Implications of Olig2 silencing in oligodendrocyte precursor cells. Neural Regen Res 18: 2649\u20132650 Doi 10.4103\/1673-5374.373666","DOI":"10.4103\/1673-5374.373666"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Fang LP, Liu Q, Meyer E, Welle A, Huang W, Scheller A, Kirchhoff F, Bai X (2023) A subset of OPCs do not express Olig2 during development which can be increased in the adult by brain injuries and complex motor learning. Glia 71: 415\u2013430 Doi 10.1002\/glia.24284","DOI":"10.1002\/glia.24284"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC (2012) Amyloid beta peptide 1\u201342 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 51: 95\u2013106 Doi https:\/\/doi.org\/10.1016\/j.ceca.2011.11.008","DOI":"10.1016\/j.ceca.2011.11.008"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. Frick EA, Emilsson V, Jonmundsson T, Steindorsdottir AE, Johnson ECB, Puerta R, Dammer EB, Shantaraman A, Cano A, Boada Met al (2024) Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nature Aging: Doi 10.1038\/s43587-024-00693-1","DOI":"10.1038\/s43587-024-00693-1"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Ge M, Zhang J, Chen S, Huang Y, Chen W, He L, Zhang Y (2022) Role of Calcium Homeostasis in Alzheimer's Disease. Neuropsychiatr Dis Treat 18: 487\u2013498 Doi 10.2147\/ndt.S350939","DOI":"10.2147\/NDT.S350939"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. Gersdorff N, Muller M, Schall A, Miosge N (2006) Secreted modular calcium-binding protein-1 localization during mouse embryogenesis. Histochem Cell Biol 126: 705\u2013712 Doi 10.1007\/s00418-006-0200-7","DOI":"10.1007\/s00418-006-0200-7"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Godoy MI, Pandey V, Wohlschlegel JA, Zhang Y (2024) Secretome analysis of oligodendrocytes and precursors reveals their roles as contributors to the extracellular matrix and potential regulators of inflammation. bioRxiv: 2024.2007.2022.604699 Doi 10.1101\/2024.07.22.604699","DOI":"10.1101\/2024.07.22.604699"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267: 564\u2013569","DOI":"10.1016\/S0021-9258(18)48531-6"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Guo Q, Ping L, Dammer EB, Duong DM, Yin L, Xu K, Shantaraman A, Fox EJ, Johnson ECB, Roberts BRet al (2023) Global analysis of the heparin-enriched plasma proteome captures matrisome-associated proteins in Alzheimer\u2019s disease. bioRxiv: 2023.2011.2006.565824 Doi 10.1101\/2023.11.06.565824","DOI":"10.1101\/2023.11.06.565824"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Guo Y, Chen S-D, You J, Huang S-Y, Chen Y-L, Zhang Y, Wang L-B, He X-Y, Deng Y-T, Zhang Y-Ret al (2024) Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease. Nature Human Behaviour: Doi 10.1038\/s41562-024-01924-6","DOI":"10.1038\/s41562-024-01924-6"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. Haque R, Watson CM, Liu J, Carter EK, Duong DM, Lah JJ, Wingo AP, Roberts BR, Johnson ECB, Saykin AJet al (2023) A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease. Sci Transl Med 15: eadg4122 Doi 10.1126\/scitranslmed.adg4122","DOI":"10.1126\/scitranslmed.adg4122"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. Heizmann CW, Braun K (1992) Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 15: 259\u2013264 Doi 10.1016\/0166\u20132236(92)90067-i","DOI":"10.1016\/0166-2236(92)90067-I"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. Hesp ZC, Yoseph RY, Suzuki R, Jukkola P, Wilson C, Nishiyama A, McTigue DM (2018) Proliferating NG2-cell-dependent angiogenesis and scar formation alter axon growth and functional recovery after spinal cord injury in mice. Journal of Neuroscience 38: 1366\u20131382","DOI":"10.1523\/JNEUROSCI.3953-16.2017"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECBet al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Sci Adv 6: Doi 10.1126\/sciadv.aaz9360","DOI":"10.1126\/sciadv.aaz9360"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"55. Hondius DC, Koopmans F, Leistner C, Pita-Illobre D, Peferoen-Baert RM, Marbus F, Paliukhovich I, Li KW, Rozemuller AJM, Hoozemans JJMet al (2021) The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease. Acta Neuropathol 141: 341\u2013358 Doi 10.1007\/s00401-020-02261-4","DOI":"10.1007\/s00401-020-02261-4"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"56. Iacopino AM, Christakos S (1990) Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proceedings of the National Academy of Sciences 87: 4078\u20134082","DOI":"10.1073\/pnas.87.11.4078"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"57. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DEM, Heizmann CW (1988) Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain research 475: 156\u2013159","DOI":"10.1016\/0006-8993(88)90210-7"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"58. Inaguma Y, Shinohara H, Inagaki T, Kato K (1992) Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease. Journal of the Neurological Sciences 110: 57\u201361 Doi https:\/\/doi.org\/10.1016\/0022-510X(92)90009-A","DOI":"10.1016\/0022-510X(92)90009-A"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"59. Iritani S, Niizato K, Emson PC (2001) Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology 21: 162\u2013167 Doi https:\/\/doi.org\/10.1046\/j.1440-1789.2001.00393.x","DOI":"10.1046\/j.1440-1789.2001.00393.x"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"60. Iwamoto N, Nishiyama E, Ohwada J, Arai H (1994) Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 177: 23\u201326 Doi 10.1016\/0304\u20133940(94)90035-3","DOI":"10.1016\/0304-3940(94)90035-3"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"61. J\u00e4kel S, Agirre E, Mendanha Falc\u00e3o A, van Bruggen D, Lee KW, Knuesel I, Malhotra D, ffrench-Constant C, Williams A, Castelo-Branco G (2019) Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566: 543\u2013547 Doi 10.1038\/s41586-019-0903-2","DOI":"10.1038\/s41586-019-0903-2"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"62. Jalal D, Sanford B, Renner B, Ten Eyck P, Laskowski J, Cooper J, Sun M, Zakharia Y, Spitz D, Dokun Aet al (2021) Detection of pro angiogenic and inflammatory biomarkers in patients with CKD. Scientific Reports 11: 8786 Doi 10.1038\/s41598-021-87710-0","DOI":"10.1038\/s41598-021-87710-0"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"63. Ji Y, Yan T, Zhu S, Wu R, Zhu M, Zhang Y, Guo C, Yao K (2021) The Integrative Analysis of Competitive Endogenous RNA Regulatory Networks in Coronary Artery Disease. Frontiers in Cardiovascular Medicine 8: Doi 10.3389\/fcvm.2021.647953","DOI":"10.3389\/fcvm.2021.647953"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"64. Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade Eet al (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nat Med 29: 1979\u20131988 Doi 10.1038\/s41591-023-02476-4","DOI":"10.1038\/s41591-023-02476-4"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"65. Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, Liu J, Betarbet R, Ping L, Yin Let al (2021) Large-Scale Deep Multi-Layer Analysis of Alzheimer\u2019s Disease Brain Reveals Strong Proteomic Disease-Related Changes Not Observed at the RNA Level. bioRxiv: 2021.2004.2005.438450 Doi 10.1101\/2021.04.05.438450","DOI":"10.1002\/alz.055041"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"66. Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, Liu J, Betarbet R, Ping L, Yin Let al (2022) Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nature Neuroscience 25: 213\u2013225 Doi 10.1038\/s41593-021-00999-y","DOI":"10.1038\/s41593-021-00999-y"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"67. Johnson ECB, Dammer EB, Duong DM, Yin L, Thambisetty M, Troncoso JC, Lah JJ, Levey AI, Seyfried NT (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13: 52 Doi 10.1186\/s13024-018-0282-4","DOI":"10.1186\/s13024-018-0282-4"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"68. Kamalian A, Ho SG, Patel M, Lewis A, Bakker A, Albert M, O\u2019Brien RJ, Moghekar A, Lutz MW (2023) Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study. Biomolecules 13: 1094","DOI":"10.3390\/biom13071094"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"69. Kavanagh T, Halder A, Drummond E (2022) Tau interactome and RNA binding proteins in neurodegenerative diseases. Molecular neurodegeneration 17: 66 Doi 10.1186\/s13024-022-00572-6","DOI":"10.1186\/s13024-022-00572-6"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"70. Kawahara M, Kuroda Y, Arispe N, Rojas E (2000) Alzheimer's \u03b2-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line *. Journal of Biological Chemistry 275: 14077\u201314083 Doi 10.1074\/jbc.275.19.14077","DOI":"10.1074\/jbc.275.19.14077"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"71. Khachaturian ZS (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Ann N Y Acad Sci 747: 1\u201311 Doi 10.1111\/j.1749-6632.1994.tb44398.x","DOI":"10.1111\/j.1749-6632.1994.tb44398.x"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"72. Klemencic M, Novinec M, Maier S, Hartmann U, Lenarcic B (2013) The heparin-binding activity of secreted modular calcium-binding protein 1 (SMOC-1) modulates its cell adhesion properties. PLoS One 8: e56839 Doi 10.1371\/journal.pone.0056839","DOI":"10.1371\/journal.pone.0056839"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"73. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59: 214\u2013225 Doi 10.1016\/j.neuron.2008.06.008","DOI":"10.1016\/j.neuron.2008.06.008"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"74. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4: 371\u2013380 Doi 10.1016\/S1474-4422(05)70099-5","DOI":"10.1016\/S1474-4422(05)70099-5"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"75. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in alzheimer's disease. Nature Reviews Neuroscience 3: 862\u2013872 Doi 10.1038\/nrn960","DOI":"10.1038\/nrn960"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"76. Leitner D, Kavanagh T, Kanshin E, Balcomb K, Pires G, Thierry M, Suazo JI, Schneider J, Ueberheide B, Drummond Eet al (2024) Differences in the cerebral amyloid angiopathy proteome in Alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol 148: 9 Doi 10.1007\/s00401-024-02767-1","DOI":"10.1007\/s00401-024-02767-1"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"77. Li Y, Chen Z, Wang Q, Lv X, Cheng Z, Wu Y, Tang F, Shen Y, Gao F (2023) Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer\u2019s disease by integrated bioinformatics. Journal of Neurology 270: 1487\u20131500 Doi 10.1007\/s00415-022-11476-2","DOI":"10.1007\/s00415-022-11476-2"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"78. Lia A, Sansevero G, Chiavegato A, Sbrissa M, Pendin D, Mariotti L, Pozzan T, Berardi N, Carmignoto G, Fasolato Cet al (2023) Rescue of astrocyte activity by the calcium sensor STIM1 restores long-term synaptic plasticity in female mice modelling Alzheimer\u2019s disease. Nature Communications 14: 1590 Doi 10.1038\/s41467-023-37240-2","DOI":"10.1038\/s41467-023-37240-2"},{"key":"ref79","unstructured":"79. Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American journal of neurodegenerative disease 3: 19"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"80. Mancini C, Zonta A, Botta G, Breda Klobus A, Valbonesi S, Pasini B, Giorgio E, Viora E, Brusco A, Brussino A (2019) A fetal case of microphthalmia and limb anomalies with abnormal neuronal migration associated with SMOC1 biallelic variants. European Journal of Medical Genetics 62: 103578 Doi https:\/\/doi.org\/10.1016\/j.ejmg.2018.11.012","DOI":"10.1016\/j.ejmg.2018.11.012"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"81. Marambaud P, Dreses-Werringloer U, Vingtdeux V (2009) Calcium signaling in neurodegeneration. Molecular Neurodegeneration 4: 20 Doi 10.1186\/1750-1326-4-20","DOI":"10.1186\/1750-1326-4-20"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"82. Marin MA, Carmichael ST (2018) Stroke in CNS white matter: Models and mechanisms. Neuroscience letters 684: 193\u2013199","DOI":"10.1016\/j.neulet.2018.07.039"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"83. Marques S, Zeisel A, Codeluppi S, van Bruggen D, Mendanha Falc\u00e3o A, Xiao L, Li H, H\u00e4ring M, Hochgerner H, Romanov RAet al (2016) Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352: 1326\u20131329 Doi 10.1126\/science.aaf6463","DOI":"10.1126\/science.aaf6463"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"84. Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, Jiang X, Abdelhady G, Galani K, Mantero Jet al (2024) Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature 632: 858\u2013868 Doi 10.1038\/s41586-024-07606-7","DOI":"10.1038\/s41586-024-07606-7"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"85. Mathys H, Peng Z, Boix CA, Victor MB, Leary N, Babu S, Abdelhady G, Jiang X, Ng AP, Ghafari Ket al (2023) Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186: 4365\u20134385.e4327 Doi https:\/\/doi.org\/10.1016\/j.cell.2023.08.039","DOI":"10.1016\/j.cell.2023.08.039"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"86. McLachlan DC, Wong L, Bergeron C, Baimbridge K (1987) Calmodulin and calbindin D28K in Alzheimer disease. Alzheimer Disease & Associated Disorders 1: 171\u2013179","DOI":"10.1097\/00002093-198701030-00009"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"87. Meng F, Zhang X, Alzheimer\u2019s Disease Neuroimaging I (2024) Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals. The Journal of Prevention of Alzheimer's Disease: Doi 10.14283\/jpad.2024.129","DOI":"10.14283\/jpad.2024.129"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"88. Merrihew GE, Park J, Plubell D, Searle BC, Keene CD, Larson EB, Bateman R, Perrin RJ, Chhatwal JP, Farlow MRet al (2023) A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer\u2019s disease. Scientific Data 10: 206 Doi 10.1038\/s41597-023-02057-7","DOI":"10.1038\/s41597-023-02057-7"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"89. Mi Z, Halfter W, Abrahamson EE, Klunk WE, Mathis CA, Mufson EJ, Ikonomovic MD (2016) Tenascin-C Is Associated with Cored Amyloid-\u03b2 Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly. Journal of Neuropathology & Experimental Neurology 75: 868\u2013876 Doi 10.1093\/jnen\/nlw062","DOI":"10.1093\/jnen\/nlw062"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"90. Montgomery MK, Bayliss J, Devereux C, Bezawork-Geleta A, Roberts D, Huang C, Schittenhelm RB, Ryan A, Townley SL, Selth LAet al (2020) SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Science translational medicine 12: Doi 10.1126\/scitranslmed.aaz8048","DOI":"10.1126\/scitranslmed.aaz8048"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"91. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL (2001) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40: 6036\u20136046 Doi 10.1021\/bi002555c","DOI":"10.1021\/bi002555c"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"92. Novinec M, Kovacic L, Skrlj N, Turk V, Lenarcic B (2008) Recombinant human SMOCs produced by in vitro refolding: calcium-binding properties and interactions with serum proteins. Protein Expr Purif 62: 75\u201382 Doi 10.1016\/j.pep.2008.07.009","DOI":"10.1016\/j.pep.2008.07.009"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"93. O\u2019Day DH, Eshak K, Myre MA (2015) Calmodulin Binding Proteins and Alzheimer\u2019s Disease. Journal of Alzheimer's Disease 46: 553\u2013569 Doi 10.3233\/JAD-142772","DOI":"10.3233\/JAD-142772"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"94. Oh HS-H, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, Timsina J, Guldner IH, Morshed N, Yang Cet al (2024) Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimer\u2019s disease. bioRxiv: 2024.2007.2022.604680 Doi 10.1101\/2024.07.22.604680","DOI":"10.1101\/2024.07.22.604680"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"95. Okada I, Hamanoue H, Terada K, Tohma T, Megarbane A, Chouery E, Abou-Ghoch J, Jalkh N, Cogulu O, Ozkinay Fet al (2011) SMOC1 is essential for ocular and limb development in humans and mice. American journal of human genetics 88: 30\u201341 Doi 10.1016\/j.ajhg.2010.11.012","DOI":"10.1016\/j.ajhg.2010.11.012"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"96. Panyard DJ, McKetney J, Deming YK, Morrow AR, Ennis GE, Jonaitis EM, Van Hulle CA, Yang C, Sung YJ, Ali Met al (2023) Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease. Alzheimer's & Dementia 19: 5447\u20135470 Doi https:\/\/doi.org\/10.1002\/alz.13130","DOI":"10.1002\/alz.13130"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"97. Pazin DE, Albrecht KH (2009) Developmental expression of Smoc1 and Smoc2 suggests potential roles in fetal gonad and reproductive tract differentiation. Dev Dyn 238: 2877\u20132890 Doi 10.1002\/dvdy.22124","DOI":"10.1002\/dvdy.22124"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"98. Pichet Binette A, Gaiteri C, Wennstr\u00f6m M, Kumar A, Hristovska I, Spotorno N, Salvad\u00f3 G, Strandberg O, Mathys H, Tsai L-Het al (2024) Proteomic changes in Alzheimer disease associated with progressive A\u03b2 plaque and tau tangle pathologies. Nature Neuroscience: Doi 10.1038\/s41593-024-01737-w","DOI":"10.1038\/s41593-024-01737-w"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"99. Ping L, Kundinger SR, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI, Seyfried NT (2020) Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease. Sci Data 7: 315 Doi 10.1038\/s41597-020-00650-8","DOI":"10.1038\/s41597-020-00650-8"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"100. Popugaeva E, Pchitskaya E, Bezprozvanny I (2017) Dysregulation of neuronal calcium homeostasis in Alzheimer's disease \u2013 A therapeutic opportunity? Biochemical and Biophysical Research Communications 483: 998\u20131004 Doi https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.053","DOI":"10.1016\/j.bbrc.2016.09.053"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"101. Rainger J, van Beusekom E, Ramsay JK, McKie L, Al-Gazali L, Pallotta R, Saponari A, Branney P, Fisher M, Morrison Het al (2011) Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice. PLoS Genet 7: e1002114 Doi 10.1371\/journal.pgen.1002114","DOI":"10.1371\/journal.pgen.1002114"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"102. Roberts JA, Varma VR, Candia J, Tanaka T, Ferrucci L, Bennett DA, Thambisetty M (2023) Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer\u2019s disease brain proteomic signature. npj Aging 9: 18 Doi 10.1038\/s41514-023-00112-6","DOI":"10.1038\/s41514-023-00112-6"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"103. Rodrigues FEP, Figueira AJ, Gomes CM, Machuqueiro M (2021) Computational Analysis of the Interactions between the S100B Extracellular Chaperone and Its Amyloid \u03b2 Peptide Client. International Journal of Molecular Sciences 22: 3629","DOI":"10.3390\/ijms22073629"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"104. Sathe G, Albert M, Darrow J, Saito A, Troncoso J, Pandey A, Moghekar A (2020) Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease. J Neurochem: Doi 10.1111\/jnc.15116","DOI":"10.1111\/jnc.15116"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"105. Schirmer L, Velmeshev D, Holmqvist S, Kaufmann M, Werneburg S, Jung D, Vistnes S, Stockley JH, Young A, Steindel Met al (2019) Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573: 75\u201382 Doi 10.1038\/s41586-019-1404-z","DOI":"10.1038\/s41586-019-1404-z"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"106. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69: 2197\u20132204","DOI":"10.1212\/01.wnl.0000271090.28148.24"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"107. Shantaraman A, Dammer EB, Ugochukwu O, Duong DM, Yin L, Carter EK, Gearing M, Chen-Plotkin A, Lee EB, Trojanowski JQet al (2024) Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer\u2019s Disease. bioRxiv: 2024.2001.2023.576728 Doi 10.1101\/2024.01.23.576728","DOI":"10.1101\/2024.01.23.576728"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"108. Shen Y, Ali M, Timsina J, Wang C, Do A, Western D, Liu M, Gorijala P, Budde J, Liu Het al (2024) Systematic proteomics in Autosomal dominant Alzheimer\u2019s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways. medRxiv: 2024.2001.2012.24301242 Doi 10.1101\/2024.01.12.24301242","DOI":"10.1101\/2024.01.12.24301242"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"109. Sung YJ, Yang C, Norton J, Johnson M, Fagan A, Bateman RJ, Perrin RJ, Morris JC, Farlow MR, Chhatwal JPet al (2023) Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease. Science Translational Medicine 15: eabq5923 Doi doi:10.1126\/scitranslmed.abq5923","DOI":"10.1126\/scitranslmed.abq5923"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"110. Taylor AIP, Davis PJ, Aubrey LD, White JBR, Parton ZN, Staniforth RA (2023) Simple, Reliable Protocol for High-Yield Solubilization of Seedless Amyloid-\u03b2 Monomer. ACS Chemical Neuroscience 14: 53\u201371 Doi 10.1021\/acschemneuro.2c00411","DOI":"10.1021\/acschemneuro.2c00411"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"111. Thierry M, Ponce J, Marta-Ariza M, Askenazi M, Faustin A, Leitner D, Pires G, Kanshin E, Drummond E, Ueberheide Bet al (2024) The influence of APOE(epsilon4) on the pTau interactome in sporadic Alzheimer's disease. Acta neuropathologica 147: 91 Doi 10.1007\/s00401-024-02744-8","DOI":"10.1007\/s00401-024-02744-8"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"112. Trautwig AN, Fox EJ, Dammer EB, Shantaraman A, Ping L, Duong DM, Levey AI, Lah JJ, Fournier CN, McEachin ZTet al (2024) Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral Sclerosis. bioRxiv: 2024.2002.2029.582840 Doi 10.1101\/2024.02.29.582840","DOI":"10.1101\/2024.02.29.582840"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"113. van der Ende EL, In 't Veld S, Hanskamp I, van der Lee S, Dijkstra JIR, Hok AHYS, Blujdea ER, van Swieten JC, Irwin DJ, Chen-Plotkin Aet al (2023) CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease. Brain 146: 4495\u20134507 Doi 10.1093\/brain\/awad213","DOI":"10.1093\/brain\/awad213"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"114. Vannahme C, Smyth N, Miosge N, Gosling S, Frie C, Paulsson M, Maurer P, Hartmann U (2002) Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. The Journal of biological chemistry 277: 37977\u201337986 Doi 10.1074\/jbc.M203830200","DOI":"10.1074\/jbc.M203830200"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"115. Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, Verkhratsky A, Rodr\u00edguez JJ, Butt AM (2020) Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiology of Aging 94: 130\u2013139 Doi https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.05.016","DOI":"10.1016\/j.neurobiolaging.2020.05.016"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"116. Wang H, Dey KK, Chen PC, Li Y, Niu M, Cho JH, Wang X, Bai B, Jiao Y, Chepyala SRet al (2020) Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease. Molecular neurodegeneration 15: 43 Doi 10.1186\/s13024-020-00384-6","DOI":"10.1186\/s13024-020-00384-6"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"117. Wang J, Xia S, Zhao J, Gong C, Xi Q, Sun W (2021) Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma. Front Mol Biosci 8: 666623 Doi 10.3389\/fmolb.2021.666623","DOI":"10.3389\/fmolb.2021.666623"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"118. Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BRet al (2023) Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease. Sci Data 10: 261 Doi 10.1038\/s41597-023-02158-3","DOI":"10.1038\/s41597-023-02158-3"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"119. Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EMet al (2019) Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun 10: 1619 Doi 10.1038\/s41467-019-09613-z","DOI":"10.1038\/s41467-019-09613-z"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"120. Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV, White B, Thambisetty M, Troncoso JCet al (2020) Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain. Nat Neurosci 23: 696\u2013700 Doi 10.1038\/s41593-020-0635-5","DOI":"10.1038\/s41593-020-0635-5"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"121. Wojtas AM, Dammer EB, Guo Q, Ping L, Shantaraman A, Duong DM, Yin L, Fox EJ, Seifar F, Lee EBet al (2024) Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimer's & Dementia 20: 4043\u20134065 Doi https:\/\/doi.org\/10.1002\/alz.13821","DOI":"10.1002\/alz.13821"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"122. Xie K, Liu Y, Hao W, Walter S, Penke B, Hartmann T, Schachner M, Fassbender K (2013) Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice. Neurobiol Aging 34: 2389\u20132398 Doi 10.1016\/j.neurobiolaging.2013.04.013","DOI":"10.1016\/j.neurobiolaging.2013.04.013"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"123. Xiong F, Ge W, Ma C (2019) Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 15: 429\u2013440 Doi 10.1016\/j.jalz.2018.10.006","DOI":"10.1016\/j.jalz.2018.10.006"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"124. Yu H, Wang M, Wang X, Jiang X (2023) Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients. FEBS Open Bio 13: 307\u2013322 Doi 10.1002\/2211-5463.13541","DOI":"10.1002\/2211-5463.13541"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"125. Zallo F, Gardenal E, Verkhratsky A, Rodr\u00edguez JJ (2018) Loss of calretinin and parvalbumin positive interneurones in the hippocampal CA1 of aged Alzheimer\u2019s disease mice. Neuroscience Letters 681: 19\u201325 Doi https:\/\/doi.org\/10.1016\/j.neulet.2018.05.027","DOI":"10.1016\/j.neulet.2018.05.027"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"126. Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, Abdelmohsen K, Bohr VA, Misra Sen J, Gorospe Met al (2019) Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nature Neuroscience 22: 719\u2013728 Doi 10.1038\/s41593-019-0372-9","DOI":"10.1038\/s41593-019-0372-9"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"127. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch Net al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34: 11929\u201311947 Doi 10.1523\/jneurosci.1860-14.2014","DOI":"10.1523\/JNEUROSCI.1860-14.2014"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"128. Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, Lah JJ, Levey AI, Seyfried NT (2020) Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease. Clin Proteomics 17: 19 Doi 10.1186\/s12014-020-09285-8","DOI":"10.1186\/s12014-020-09285-8"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5229472\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5229472\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:23:46Z","timestamp":1733156626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5229472\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":128,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5229472\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s00401-024-02819-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,11,1]]},"subtype":"preprint"}}